{
    "@context": "https://api.researchmap.jp/researcher.jsonld",
    "@id": "https://api.researchmap.jp/read0013595?format=json",
    "@type": "researchers",
    "rm:user_id": "1000029445",
    "rm:creator_id": "1000029445",
    "rm:creator_type": "myself",
    "rm:created": "2009-09-24T15:00:00Z",
    "rm:modifier_id": "1000029445",
    "rm:modifier_type": "myself",
    "rm:modified": "2020-06-07T22:51:31Z",
    "permalink": "read0013595",
    "family_name": {
        "ja": "濱田",
        "ja-Kana": "ハマダ",
        "en": "Hamada"
    },
    "given_name": {
        "ja": "和成",
        "ja-Kana": "カズシゲ",
        "en": "Kazushige"
    },
    "display_name_kana": "disclosed",
    "display_nickname": "disclosed",
    "display_image": "disclosed",
    "display_contact_point": "disclosed",
    "affiliations": [
        {
            "affiliation": {
                "ja": "京都工芸繊維大学",
                "en": "Kyoto Institute of Technology"
            },
            "section": {
                "ja": "大学院工芸科学研究科応用生物学部門",
                "en": "Department of Biotechnology"
            },
            "job": {
                "ja": "助教",
                "en": "Assistant Professor"
            },
            "display_affiliation": "disclosed",
            "display_job": "disclosed",
            "rm:institution_code": "0288501000"
        }
    ],
    "degrees": [
        {
            "degree": {
                "ja": "理学博士",
                "en": "Doctor of Science"
            },
            "degree_institution": {
                "ja": "京都大学",
                "en": "Kyoto University"
            },
            "display_degree": "disclosed",
            "rm:institution_code": "0280000000"
        }
    ],
    "display_profile": "disclosed",
    "see_also": [
        {
            "label": "j_global",
            "@id": "https://jglobal.jst.go.jp/detail?JGLOBAL_ID=200901078604949316"
        },
        {
            "label": "url",
            "@id": "http://www.bio.kit.ac.jp/"
        }
    ],
    "display_url": "disclosed",
    "identifiers": {
        "j_global_id": [
            "200901078604949316"
        ]
    },
    "rm:erad_id_verified": true,
    "rm:orc_id_verified": false,
    "display_erad_id": "closed",
    "display_orc_id": "closed",
    "display_researcher_id": "disclosed",
    "display_j_global_id": "disclosed",
    "@graph": [
        {
            "@id": "https://api.researchmap.jp/read0013595/research_interests",
            "@type": "research_interests",
            "@reverse": "https://api.researchmap.jp/read0013595",
            "total_items": 2,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0013595/research_interests/1316517",
                    "@type": "research_interests",
                    "@reverse": "https://api.researchmap.jp/read0013595/research_interests",
                    "rm:id": "1316517",
                    "rm:user_id": "1000029445",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000029445",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-09-24T15:00:00Z",
                    "rm:modifier_id": "1000029445",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2009-09-24T15:00:00Z",
                    "keyword": {
                        "ja": "interferon anti-virus oligoadenylate synthetase"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0013595/research_interests/1316516",
                    "@type": "research_interests",
                    "@reverse": "https://api.researchmap.jp/read0013595/research_interests",
                    "rm:id": "1316516",
                    "rm:user_id": "1000029445",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000029445",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-09-24T15:00:00Z",
                    "rm:modifier_id": "1000029445",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2009-09-24T15:00:00Z",
                    "keyword": {
                        "en": "interferon anti-virus oligoadenylate synthetase"
                    }
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/read0013595/research_areas",
            "@type": "research_areas",
            "@reverse": "https://api.researchmap.jp/read0013595",
            "total_items": 1,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0013595/research_areas/775650",
                    "@type": "research_areas",
                    "@reverse": "https://api.researchmap.jp/read0013595/research_areas",
                    "rm:id": "775650",
                    "rm:user_id": "1000029445",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000029445",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-09-24T15:00:00Z",
                    "rm:modifier_id": "1000029445",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2009-09-24T15:00:00Z",
                    "discipline_number": "A189",
                    "item_number": "A43010",
                    "discipline": {
                        "ja": "ライフサイエンス",
                        "en": "Life sciences"
                    },
                    "research_field": {
                        "ja": "分子生物学",
                        "en": "Molecular biology"
                    }
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/read0013595/research_experience",
            "@type": "research_experience",
            "@reverse": "https://api.researchmap.jp/read0013595",
            "total_items": 3,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0013595/research_experience/3062728",
                    "@type": "research_experience",
                    "@reverse": "https://api.researchmap.jp/read0013595/research_experience",
                    "rm:id": "3062728",
                    "rm:user_id": "1000029445",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000029445",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-09-24T15:00:00Z",
                    "rm:modifier_id": "1000029445",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2009-09-24T15:00:00Z",
                    "from_date": "1987",
                    "to_date": "1989",
                    "rm:institution_code": "9999999999",
                    "affiliation": {
                        "ja": "米国国立衛生研究所 Visiting Fellow"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0013595/research_experience/3062726",
                    "@type": "research_experience",
                    "@reverse": "https://api.researchmap.jp/read0013595/research_experience",
                    "rm:id": "3062726",
                    "rm:user_id": "1000029445",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000029445",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-09-24T15:00:00Z",
                    "rm:modifier_id": "1000029445",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2009-09-24T15:00:00Z",
                    "from_date": "1987",
                    "to_date": "1989",
                    "rm:institution_code": "T139000000",
                    "affiliation": {
                        "ja": "米国国立衛生学研究所",
                        "en": "National Institutes of Health USA,"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0013595/research_experience/3062727",
                    "@type": "research_experience",
                    "@reverse": "https://api.researchmap.jp/read0013595/research_experience",
                    "rm:id": "3062727",
                    "rm:user_id": "1000029445",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000029445",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-09-24T15:00:00Z",
                    "rm:modifier_id": "1000029445",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2009-09-24T15:00:00Z",
                    "rm:institution_code": "9999999999",
                    "affiliation": {
                        "en": "Visiting Fellow"
                    }
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/read0013595/education",
            "@type": "education",
            "@reverse": "https://api.researchmap.jp/read0013595",
            "total_items": 4,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0013595/education/1926884",
                    "@type": "education",
                    "@reverse": "https://api.researchmap.jp/read0013595/education",
                    "rm:id": "1926884",
                    "rm:user_id": "1000029445",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000029445",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-09-24T15:00:00Z",
                    "rm:modifier_id": "1000029445",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2009-09-24T15:00:00Z",
                    "to_date": "1987",
                    "rm:institution_code": "0280000000",
                    "affiliation": {
                        "ja": "京都大学",
                        "en": "Kyoto University"
                    },
                    "department": {
                        "ja": "理学研究科"
                    },
                    "course": {
                        "ja": "植物学専攻"
                    },
                    "address_country": "JPN"
                },
                {
                    "@id": "https://api.researchmap.jp/read0013595/education/1926882",
                    "@type": "education",
                    "@reverse": "https://api.researchmap.jp/read0013595/education",
                    "rm:id": "1926882",
                    "rm:user_id": "1000029445",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000029445",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-09-24T15:00:00Z",
                    "rm:modifier_id": "1000029445",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2009-09-24T15:00:00Z",
                    "to_date": "1987",
                    "rm:institution_code": "0280000000",
                    "affiliation": {
                        "ja": "京都大学",
                        "en": "Kyoto University"
                    },
                    "department": {
                        "en": "Graduate School, Division of Natural Science"
                    },
                    "course": {
                        "en": "Botany"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0013595/education/1926885",
                    "@type": "education",
                    "@reverse": "https://api.researchmap.jp/read0013595/education",
                    "rm:id": "1926885",
                    "rm:user_id": "1000029445",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000029445",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-09-24T15:00:00Z",
                    "rm:modifier_id": "1000029445",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2009-09-24T15:00:00Z",
                    "to_date": "1982",
                    "rm:institution_code": "2643000000",
                    "affiliation": {
                        "ja": "甲南大学",
                        "en": "Konan University"
                    },
                    "department": {
                        "ja": "理学部"
                    },
                    "course": {
                        "ja": "生物学科"
                    },
                    "address_country": "JPN"
                },
                {
                    "@id": "https://api.researchmap.jp/read0013595/education/1926883",
                    "@type": "education",
                    "@reverse": "https://api.researchmap.jp/read0013595/education",
                    "rm:id": "1926883",
                    "rm:user_id": "1000029445",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000029445",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-09-24T15:00:00Z",
                    "rm:modifier_id": "1000029445",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2009-09-24T15:00:00Z",
                    "to_date": "1982",
                    "rm:institution_code": "2643000000",
                    "affiliation": {
                        "ja": "甲南大学",
                        "en": "Konan University"
                    },
                    "department": {
                        "en": "Faculty of Science"
                    }
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/read0013595/misc",
            "@type": "misc",
            "@reverse": "https://api.researchmap.jp/read0013595",
            "total_items": 60,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0013595/misc/10579179",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0013595/misc",
                    "rm:id": "10579179",
                    "rm:user_id": "1000029445",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000029445",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-09-24T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-06-07T22:51:31Z",
                    "paper_title": {
                        "en": "In vivo interferon system assessed by 2 &apos;-5 &apos; oligoadenylate synthetase activity in chronic hepatitis C virus patients treated with pegylated interferon and ribavirin"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Michiko Shindo"
                            },
                            {
                                "name": "Kazushige Hamada"
                            },
                            {
                                "name": "Teruhisa Morikawa"
                            },
                            {
                                "name": "Yuichi Harano"
                            },
                            {
                                "name": "Tomoaki Nakajima"
                            },
                            {
                                "name": "Tadao Okuno"
                            }
                        ]
                    },
                    "description": {
                        "en": "Aim: 2&apos;,5&apos; oligoadenylate synthetase (2-5AS), an enzyme induced by interferon, is an accurate indicator of the antiviral effect of interferon. We measured it during pegylated interferon based therapies in patients with chronic hepatitis C virus (HCV) in order to determine the dynamics of antiviral status in vivo and the relationship between the response to exogenous interferon and the outcome of therapy.\nMethods: A total of 160 patients with chronic HCV were treated with pegylated interferon alfa 2a or 2b or non-pegylated interferon, with or without ribavirin. Serum 2-5AS activity was measured by radioimmunoassay assay kits every 2 weeks.\nResults: In 60 patients treated with pegylated interferon alfa 2a or 2b, 2-5AS levels increased to 7-40 times (average 235 pmol/dL) above the pretreatment levels (30 pmol/dL), which were significantly higher than the levels during non-pegylated interferon therapy. Ribavirin did not enhance 2-5AS levels. 2-5AS levels between sustained virological response (SVR) and non-SVR, including null responders to pegylated interferon plus ribavirin therapy were not significantly different.\nConclusion: 2-5AS levels were significantly higher in patients treated with pegylated interferon than in those treated with non-pegylated interferon, suggesting that pegylated interferon is more potent at inducing interferon response genes resulting in an improved antiviral effect. Ribavirin did not appear to be related to interferon response gene induction."
                    },
                    "publisher": {
                        "en": "WILEY-BLACKWELL"
                    },
                    "publication_date": "2008-12",
                    "publication_name": {
                        "en": "HEPATOLOGY RESEARCH"
                    },
                    "volume": "38",
                    "number": "12",
                    "starting_page": "1213",
                    "ending_page": "1220",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1111/j.1872-034X.2008.00397.x"
                        ],
                        "issn": [
                            "1386-6346"
                        ],
                        "wos_id": [
                            "WOS:000260537800007"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1111/j.1872-034X.2008.00397.x",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000260537800007&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0013595/misc/10579149",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0013595/misc",
                    "rm:id": "10579149",
                    "rm:user_id": "1000029445",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000029445",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-09-24T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-06-07T22:51:31Z",
                    "paper_title": {
                        "en": "In vivo interferon system assessed by 2 &apos;-5 &apos; oligoadenylate synthetase activity in chronic hepatitis C virus patients treated with pegylated interferon and ribavirin"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Michiko Shindo"
                            },
                            {
                                "name": "Kazushige Hamada"
                            },
                            {
                                "name": "Teruhisa Morikawa"
                            },
                            {
                                "name": "Yuichi Harano"
                            },
                            {
                                "name": "Tomoaki Nakajima"
                            },
                            {
                                "name": "Tadao Okuno"
                            }
                        ]
                    },
                    "description": {
                        "en": "Aim: 2&apos;,5&apos; oligoadenylate synthetase (2-5AS), an enzyme induced by interferon, is an accurate indicator of the antiviral effect of interferon. We measured it during pegylated interferon based therapies in patients with chronic hepatitis C virus (HCV) in order to determine the dynamics of antiviral status in vivo and the relationship between the response to exogenous interferon and the outcome of therapy.\nMethods: A total of 160 patients with chronic HCV were treated with pegylated interferon alfa 2a or 2b or non-pegylated interferon, with or without ribavirin. Serum 2-5AS activity was measured by radioimmunoassay assay kits every 2 weeks.\nResults: In 60 patients treated with pegylated interferon alfa 2a or 2b, 2-5AS levels increased to 7-40 times (average 235 pmol/dL) above the pretreatment levels (30 pmol/dL), which were significantly higher than the levels during non-pegylated interferon therapy. Ribavirin did not enhance 2-5AS levels. 2-5AS levels between sustained virological response (SVR) and non-SVR, including null responders to pegylated interferon plus ribavirin therapy were not significantly different.\nConclusion: 2-5AS levels were significantly higher in patients treated with pegylated interferon than in those treated with non-pegylated interferon, suggesting that pegylated interferon is more potent at inducing interferon response genes resulting in an improved antiviral effect. Ribavirin did not appear to be related to interferon response gene induction."
                    },
                    "publisher": {
                        "en": "WILEY-BLACKWELL"
                    },
                    "publication_date": "2008-12",
                    "publication_name": {
                        "en": "HEPATOLOGY RESEARCH"
                    },
                    "volume": "38",
                    "number": "12",
                    "starting_page": "1213",
                    "ending_page": "1220",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1111/j.1872-034X.2008.00397.x"
                        ],
                        "issn": [
                            "1386-6346"
                        ],
                        "wos_id": [
                            "WOS:000260537800007"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1111/j.1872-034X.2008.00397.x",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000260537800007&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0013595/misc/10579178",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0013595/misc",
                    "rm:id": "10579178",
                    "rm:user_id": "1000029445",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000029445",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-09-24T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-17T12:56:25Z",
                    "paper_title": {
                        "en": "Early reduction of infected hepatocytes by activated immunity at the time of interferon withdrawal hepatitis followed by lamivudine administration resulted in higher seroconversion in hepatitis Be antigen-positive patients with chronic hepatitis B"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "M Shindo"
                            },
                            {
                                "name": "K Hamada"
                            },
                            {
                                "name": "A Muramatsu"
                            },
                            {
                                "name": "T Morikawa"
                            },
                            {
                                "name": "T Okuno"
                            }
                        ]
                    },
                    "description": {
                        "en": "Background. It has been found that the efficacy of lamivudine (LAM) therapy can be improved by preceding administration with a short course of corticosteroid that induces a flare of the disease upon its withdrawal. Because of the side effects of corticosteroid, we tested the effect of a short course of interferon (IFN) as the primer instead of prednisolone, which was followed by LAM when the hepatitis flare occurred. The incidence of LAM resistance mutations and the effect of core promoter and precore mutations on the durability of the responses were also studied. Methods. Patients treated with interferon (IFN)-LAM therapy (n = 73) were compared to those treated with IFN alone (n = 117). The IFN-LAM group received IFN-alpha MU/day, t.i.w. for a 3-month period. LAM (10mg/day during 1 year) was started when IFN withdrawal hepatitis occurred during 2-10 months after stopping IFN. The LAM-resistant, core promoter, and precore mutations were examined by sequencing. Results. (1) The IFN-LAM group developed exacerbated hepatitis following IFN withdrawal in 63 patients before starting LAM therapy. The seroconversion (SC) rate was significantly higher in the IFN-LAM group than in the IFN-alone group (61% vs 26%, P = 0.0001). (2) The LAM resistance mutation rate was 31% at 1 year after initiating LAM therapy. (3) In a stepwise discriminant-function analysis, decreased level of HBeAg determined at 4 weeks after LAM administration and increased level of HBeAb before the start of LAM administration contributed significantly on seroconversion to anti-HBe (P = 0.0073 and 0.004, respectively). (4) The reappearance rate of HBeAg within 6 months after the therapy (relapse) was 33% in the IFN-LAM group and 10% in the IFN-alone group. The prevalence of core promoter and precore mutations did not change before and after the therapy, nor did these mutations correlate with the relapse after stopping IFN-LAM therapy. Conclusions. (1) Our findings suggest that early reduction of infected hepatocytes expressed by HBeAg by LAM may contribute to a high SC rate of IFN-LAM therapy. (2) The emergence of LAM-resistant mutations was similar to the previously reported rate, and neither core promoter nor precore mutations correlated with relapse of seroconverters after IFN-LAM withdrawal."
                    },
                    "publisher": {
                        "en": "SPRINGER TOKYO"
                    },
                    "publication_date": "2006-02",
                    "publication_name": {
                        "en": "JOURNAL OF GASTROENTEROLOGY"
                    },
                    "volume": "41",
                    "number": "2",
                    "starting_page": "151",
                    "ending_page": "157",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "cinii_na_id": [
                            "10017421214"
                        ],
                        "doi": [
                            "10.1007/s00535-005-1734-5"
                        ],
                        "issn": [
                            "0944-1174"
                        ],
                        "pm_id": [
                            "16568374"
                        ],
                        "wos_id": [
                            "WOS:000236381400008"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "cinii_articles",
                            "@id": "http://ci.nii.ac.jp/naid/10017421214",
                            "is_downloadable": false
                        },
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1007/s00535-005-1734-5",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/16568374",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000236381400008&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0013595/misc/10579148",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0013595/misc",
                    "rm:id": "10579148",
                    "rm:user_id": "1000029445",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000029445",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-09-24T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-17T12:56:25Z",
                    "paper_title": {
                        "en": "Early reduction of infected hepatocytes by activated immunity at the time of interferon withdrawal hepatitis followed by lamivudine administration resulted in higher seroconversion in hepatitis Be antigen-positive patients with chronic hepatitis B"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "M Shindo"
                            },
                            {
                                "name": "K Hamada"
                            },
                            {
                                "name": "A Muramatsu"
                            },
                            {
                                "name": "T Morikawa"
                            },
                            {
                                "name": "T Okuno"
                            }
                        ]
                    },
                    "description": {
                        "en": "Background. It has been found that the efficacy of lamivudine (LAM) therapy can be improved by preceding administration with a short course of corticosteroid that induces a flare of the disease upon its withdrawal. Because of the side effects of corticosteroid, we tested the effect of a short course of interferon (IFN) as the primer instead of prednisolone, which was followed by LAM when the hepatitis flare occurred. The incidence of LAM resistance mutations and the effect of core promoter and precore mutations on the durability of the responses were also studied. Methods. Patients treated with interferon (IFN)-LAM therapy (n = 73) were compared to those treated with IFN alone (n = 117). The IFN-LAM group received IFN-alpha MU/day, t.i.w. for a 3-month period. LAM (10mg/day during 1 year) was started when IFN withdrawal hepatitis occurred during 2-10 months after stopping IFN. The LAM-resistant, core promoter, and precore mutations were examined by sequencing. Results. (1) The IFN-LAM group developed exacerbated hepatitis following IFN withdrawal in 63 patients before starting LAM therapy. The seroconversion (SC) rate was significantly higher in the IFN-LAM group than in the IFN-alone group (61% vs 26%, P = 0.0001). (2) The LAM resistance mutation rate was 31% at 1 year after initiating LAM therapy. (3) In a stepwise discriminant-function analysis, decreased level of HBeAg determined at 4 weeks after LAM administration and increased level of HBeAb before the start of LAM administration contributed significantly on seroconversion to anti-HBe (P = 0.0073 and 0.004, respectively). (4) The reappearance rate of HBeAg within 6 months after the therapy (relapse) was 33% in the IFN-LAM group and 10% in the IFN-alone group. The prevalence of core promoter and precore mutations did not change before and after the therapy, nor did these mutations correlate with the relapse after stopping IFN-LAM therapy. Conclusions. (1) Our findings suggest that early reduction of infected hepatocytes expressed by HBeAg by LAM may contribute to a high SC rate of IFN-LAM therapy. (2) The emergence of LAM-resistant mutations was similar to the previously reported rate, and neither core promoter nor precore mutations correlated with relapse of seroconverters after IFN-LAM withdrawal."
                    },
                    "publisher": {
                        "en": "SPRINGER TOKYO"
                    },
                    "publication_date": "2006-02",
                    "publication_name": {
                        "en": "JOURNAL OF GASTROENTEROLOGY"
                    },
                    "volume": "41",
                    "number": "2",
                    "starting_page": "151",
                    "ending_page": "157",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "cinii_na_id": [
                            "80019217174"
                        ],
                        "doi": [
                            "10.1007/s00535-005-1734-5"
                        ],
                        "issn": [
                            "0944-1174"
                        ],
                        "pm_id": [
                            "16568374"
                        ],
                        "wos_id": [
                            "WOS:000236381400008"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "cinii_articles",
                            "@id": "http://ci.nii.ac.jp/naid/80019217174",
                            "is_downloadable": false
                        },
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1007/s00535-005-1734-5",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/16568374",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000236381400008&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0013595/misc/10579177",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0013595/misc",
                    "rm:id": "10579177",
                    "rm:user_id": "1000029445",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000029445",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-09-24T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-04-28T08:20:51Z",
                    "paper_title": {
                        "en": "The predictive value of liver fibrosis in determining the effectiveness of interferon and lamivudine therapies for chronic hepatitis B"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "M Shindo"
                            },
                            {
                                "name": "K Hamada"
                            },
                            {
                                "name": "K Nishioji"
                            },
                            {
                                "name": "A Muramatsu"
                            },
                            {
                                "name": "Y Oda"
                            },
                            {
                                "name": "T Okuno"
                            }
                        ]
                    },
                    "description": {
                        "en": "Backgound. To determine the best indicator of the effective use of interferon and lamivudine for the treatment of hepatitis B e antigen-positive chronic hepatitis, we retrospectively analyzed histologic and virologic status in 200 patients who were treated with interferon and 45 patients who were treated with lamivudine. Methods. Histological grading and staging scores were determined by international criteria and the METAVIR scoring system. The YMDD motif associated with lamivudine resistance was analyzed by the sequencing of hepatitis B virus (HBV) DNA. Results. Of 200 interferon-treated patients, 62 (31%) seroconverted to anti-hepatitis B e (anti-HBe). Multivariate analysis showed that the significantly important predictors of response were a higher grading score (P = 0.0056) and lower staging score (P = 0.0010). Twenty (44%) of the 45 lamivudine-treated patients seroconverted to anti-HBe, and multivariate analysis showed that the significantly important predictors of response were a higher alanine aminotransferase (ALT) level (P = 0.0034) and lower hepatitis B e antigen levels (P = 0.0128). YMDD mutations occurred during therapy in 12 patients (27%). The significantly important predictor of the development of mutation was a higher staging score (P = 0.0226). Conclusions. Both interferon and lamivudine were effective for patients with high ALT levels, but interferon's efficacy appeared to be limited by the degree of fibrosis. Lamivudine appeared to be effective irrespective of the degree of fibrosis, but YMDD mutations seemed to develop sooner in patients with advanced liver fibrosis."
                    },
                    "publisher": {
                        "en": "SPRINGER-VERLAG TOKYO"
                    },
                    "publication_date": "2004-03",
                    "publication_name": {
                        "en": "JOURNAL OF GASTROENTEROLOGY"
                    },
                    "volume": "39",
                    "number": "3",
                    "starting_page": "260",
                    "ending_page": "267",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "cinii_na_id": [
                            "10012842954"
                        ],
                        "doi": [
                            "10.1007/s00535-003-1293-6"
                        ],
                        "issn": [
                            "0944-1174"
                        ],
                        "pm_id": [
                            "15065004"
                        ],
                        "wos_id": [
                            "WOS:000220785600009"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "cinii_articles",
                            "@id": "http://ci.nii.ac.jp/naid/10012842954",
                            "is_downloadable": false
                        },
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1007/s00535-003-1293-6",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/15065004",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000220785600009&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0013595/misc/10579147",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0013595/misc",
                    "rm:id": "10579147",
                    "rm:user_id": "1000029445",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000029445",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-09-24T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-04-28T08:20:51Z",
                    "paper_title": {
                        "en": "The predictive value of liver fibrosis in determining the effectiveness of interferon and lamivudine therapies for chronic hepatitis B"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "M Shindo"
                            },
                            {
                                "name": "K Hamada"
                            },
                            {
                                "name": "K Nishioji"
                            },
                            {
                                "name": "A Muramatsu"
                            },
                            {
                                "name": "Y Oda"
                            },
                            {
                                "name": "T Okuno"
                            }
                        ]
                    },
                    "description": {
                        "en": "Backgound. To determine the best indicator of the effective use of interferon and lamivudine for the treatment of hepatitis B e antigen-positive chronic hepatitis, we retrospectively analyzed histologic and virologic status in 200 patients who were treated with interferon and 45 patients who were treated with lamivudine. Methods. Histological grading and staging scores were determined by international criteria and the METAVIR scoring system. The YMDD motif associated with lamivudine resistance was analyzed by the sequencing of hepatitis B virus (HBV) DNA. Results. Of 200 interferon-treated patients, 62 (31%) seroconverted to anti-hepatitis B e (anti-HBe). Multivariate analysis showed that the significantly important predictors of response were a higher grading score (P = 0.0056) and lower staging score (P = 0.0010). Twenty (44%) of the 45 lamivudine-treated patients seroconverted to anti-HBe, and multivariate analysis showed that the significantly important predictors of response were a higher alanine aminotransferase (ALT) level (P = 0.0034) and lower hepatitis B e antigen levels (P = 0.0128). YMDD mutations occurred during therapy in 12 patients (27%). The significantly important predictor of the development of mutation was a higher staging score (P = 0.0226). Conclusions. Both interferon and lamivudine were effective for patients with high ALT levels, but interferon's efficacy appeared to be limited by the degree of fibrosis. Lamivudine appeared to be effective irrespective of the degree of fibrosis, but YMDD mutations seemed to develop sooner in patients with advanced liver fibrosis."
                    },
                    "publisher": {
                        "en": "SPRINGER-VERLAG TOKYO"
                    },
                    "publication_date": "2004-03",
                    "publication_name": {
                        "en": "JOURNAL OF GASTROENTEROLOGY"
                    },
                    "volume": "39",
                    "number": "3",
                    "starting_page": "260",
                    "ending_page": "267",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "cinii_na_id": [
                            "10012842954"
                        ],
                        "doi": [
                            "10.1007/s00535-003-1293-6"
                        ],
                        "issn": [
                            "0944-1174"
                        ],
                        "pm_id": [
                            "15065004"
                        ],
                        "wos_id": [
                            "WOS:000220785600009"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "cinii_articles",
                            "@id": "http://ci.nii.ac.jp/naid/10012842954",
                            "is_downloadable": false
                        },
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1007/s00535-003-1293-6",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/15065004",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000220785600009&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0013595/misc/10579176",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0013595/misc",
                    "rm:id": "10579176",
                    "rm:user_id": "1000029445",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000029445",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-09-24T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-02T05:56:44Z",
                    "paper_title": {
                        "en": "Genetic changes in hypervariable region 1 as a possible mechanism for biochemical responders with interferon therapy"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "M Shindo"
                            },
                            {
                                "name": "K Hamada"
                            },
                            {
                                "name": "Y Oda"
                            },
                            {
                                "name": "T Okuno"
                            }
                        ]
                    },
                    "description": {
                        "en": "Aim: Approximately 10% of chronic hepatitis C patients who were treated with interferon have a sustained normalization of amino transferase levels after interferon therapy without HCV RNA clearance. We investigated genetic change in hypervariable region 1 (HVR 1) to see if the mutation in this region is responsible for their sustained biochemical response and relapse thereafter. A total of 250 patients with chronic hepatitis C who were treated with interferon were studied for 8 to 11 years post therapy. Of these, 26 were biochemical responders (BR) whose ALT remained normal without viral clearance for more than 6 months after IFN therapy. HVR 1 was examined by direct sequencing of the PCR products, and found that no significant HVR 1 differences were observed in samples obtained pretreatment, posttreatment or during flares from these patients, suggesting that mutations in this region were not responsible for either the persistence of the HCV RNA or for the ALT relapses thereafter."
                    },
                    "publisher": {
                        "en": "BLACKWELL MUNKSGAARD"
                    },
                    "publication_date": "2002-04",
                    "publication_name": {
                        "en": "LIVER"
                    },
                    "volume": "22",
                    "number": "2",
                    "starting_page": "184",
                    "ending_page": "185",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "misc_type": "report_scientific_journal",
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1034/j.1600-0676.2002.01572.x"
                        ],
                        "issn": [
                            "0106-9543"
                        ],
                        "wos_id": [
                            "WOS:000176099400015"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1034/j.1600-0676.2002.01572.x",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000176099400015&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0013595/misc/10579146",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0013595/misc",
                    "rm:id": "10579146",
                    "rm:user_id": "1000029445",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000029445",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-09-24T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-02T05:56:44Z",
                    "paper_title": {
                        "en": "Genetic changes in hypervariable region 1 as a possible mechanism for biochemical responders with interferon therapy"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "M Shindo"
                            },
                            {
                                "name": "K Hamada"
                            },
                            {
                                "name": "Y Oda"
                            },
                            {
                                "name": "T Okuno"
                            }
                        ]
                    },
                    "description": {
                        "en": "Aim: Approximately 10% of chronic hepatitis C patients who were treated with interferon have a sustained normalization of amino transferase levels after interferon therapy without HCV RNA clearance. We investigated genetic change in hypervariable region 1 (HVR 1) to see if the mutation in this region is responsible for their sustained biochemical response and relapse thereafter. A total of 250 patients with chronic hepatitis C who were treated with interferon were studied for 8 to 11 years post therapy. Of these, 26 were biochemical responders (BR) whose ALT remained normal without viral clearance for more than 6 months after IFN therapy. HVR 1 was examined by direct sequencing of the PCR products, and found that no significant HVR 1 differences were observed in samples obtained pretreatment, posttreatment or during flares from these patients, suggesting that mutations in this region were not responsible for either the persistence of the HCV RNA or for the ALT relapses thereafter."
                    },
                    "publisher": {
                        "en": "BLACKWELL MUNKSGAARD"
                    },
                    "publication_date": "2002-04",
                    "publication_name": {
                        "en": "LIVER"
                    },
                    "volume": "22",
                    "number": "2",
                    "starting_page": "184",
                    "ending_page": "185",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "misc_type": "report_scientific_journal",
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1034/j.1600-0676.2002.01572.x"
                        ],
                        "issn": [
                            "0106-9543"
                        ],
                        "wos_id": [
                            "WOS:000176099400015"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1034/j.1600-0676.2002.01572.x",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000176099400015&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0013595/misc/10579174",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0013595/misc",
                    "rm:id": "10579174",
                    "rm:user_id": "1000029445",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000029445",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-09-24T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-06-06T15:24:41Z",
                    "paper_title": {
                        "en": "Long-term follow-up study of sustained biochemical responders with interferon therapy"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "M Shindo"
                            },
                            {
                                "name": "K Hamada"
                            },
                            {
                                "name": "Y Oda"
                            },
                            {
                                "name": "T Okuno"
                            }
                        ]
                    },
                    "description": {
                        "en": "A proportion of chronic hepatitis C patients who were treated with interferon have a sustained normalization of transaminase levels after interferon therapy without hepatitis C virus (HCV)-RNA clearance. We determined their clinical characteristics and long-term outcome in relation to progression to liver cirrhosis (LC) and the development of hepatocellular carcinoma (HCC). A total of 250 patients with chronic hepatitis C who were treated with interferon were studied for 8 to 11 years' posttherapy. Sixty-seven patients (27%) were complete responders with clearance of HCV RNA. Twenty-six (10%) were biochemical responders who had sustained normal alanine transaminase (ALT) levels without viral clearance. The remaining patients were short-term responders (n = 70) and nonresponders (n = 87). Biochemical responders were older, had higher levels of pretreatment HCV RNA in serum than complete responders, and had less advanced liver histology than nonresponders. Histologic grading scores decreased significantly gt the end of therapy, while the staging scores did not change significantly. The annual incidence of cirrhosis was 0% in biochemical and complete responders, which was significantly lower than nonresponders and the controls (P = .0001). The annual incidence of HCC was 0.37% in complete responders and 0.50% in biochemical responders, which was significantly lower than nonresponders (P = .0001 for both), Our findings suggest that biochemical responders had high pretreatment viral levels with less advanced liver histology, and their long-term outcome appeared to be good irrespective of the persistence of the virus."
                    },
                    "publisher": {
                        "en": "W B SAUNDERS CO"
                    },
                    "publication_date": "2001-05",
                    "publication_name": {
                        "en": "HEPATOLOGY"
                    },
                    "volume": "33",
                    "number": "5",
                    "starting_page": "1299",
                    "ending_page": "1302",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1053/jhep.2001.24100"
                        ],
                        "issn": [
                            "0270-9139"
                        ],
                        "wos_id": [
                            "WOS:000168363000034"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1053/jhep.2001.24100",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000168363000034&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0013595/misc/10579144",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0013595/misc",
                    "rm:id": "10579144",
                    "rm:user_id": "1000029445",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000029445",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-09-24T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-06-06T15:24:41Z",
                    "paper_title": {
                        "en": "Long-term follow-up study of sustained biochemical responders with interferon therapy"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "M Shindo"
                            },
                            {
                                "name": "K Hamada"
                            },
                            {
                                "name": "Y Oda"
                            },
                            {
                                "name": "T Okuno"
                            }
                        ]
                    },
                    "description": {
                        "en": "A proportion of chronic hepatitis C patients who were treated with interferon have a sustained normalization of transaminase levels after interferon therapy without hepatitis C virus (HCV)-RNA clearance. We determined their clinical characteristics and long-term outcome in relation to progression to liver cirrhosis (LC) and the development of hepatocellular carcinoma (HCC). A total of 250 patients with chronic hepatitis C who were treated with interferon were studied for 8 to 11 years' posttherapy. Sixty-seven patients (27%) were complete responders with clearance of HCV RNA. Twenty-six (10%) were biochemical responders who had sustained normal alanine transaminase (ALT) levels without viral clearance. The remaining patients were short-term responders (n = 70) and nonresponders (n = 87). Biochemical responders were older, had higher levels of pretreatment HCV RNA in serum than complete responders, and had less advanced liver histology than nonresponders. Histologic grading scores decreased significantly gt the end of therapy, while the staging scores did not change significantly. The annual incidence of cirrhosis was 0% in biochemical and complete responders, which was significantly lower than nonresponders and the controls (P = .0001). The annual incidence of HCC was 0.37% in complete responders and 0.50% in biochemical responders, which was significantly lower than nonresponders (P = .0001 for both), Our findings suggest that biochemical responders had high pretreatment viral levels with less advanced liver histology, and their long-term outcome appeared to be good irrespective of the persistence of the virus."
                    },
                    "publisher": {
                        "en": "W B SAUNDERS CO"
                    },
                    "publication_date": "2001-05",
                    "publication_name": {
                        "en": "HEPATOLOGY"
                    },
                    "volume": "33",
                    "number": "5",
                    "starting_page": "1299",
                    "ending_page": "1302",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1053/jhep.2001.24100"
                        ],
                        "issn": [
                            "0270-9139"
                        ],
                        "wos_id": [
                            "WOS:000168363000034"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1053/jhep.2001.24100",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000168363000034&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0013595/misc/10579175",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0013595/misc",
                    "rm:id": "10579175",
                    "rm:user_id": "1000029445",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000029445",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-09-24T15:00:00Z",
                    "rm:modifier_id": "B000000004",
                    "rm:modifier_type": "system",
                    "rm:modified": "2009-09-24T15:00:00Z",
                    "paper_title": {
                        "ja": "Cloning of a novel 2',5'-oligoadenylate synthetase-like molecule, Oasl5 in mice"
                    },
                    "authors": {
                        "ja": [
                            {
                                "name": "SHIBATA S"
                            },
                            {
                                "name": "KAKUTA S"
                            },
                            {
                                "name": "HAMADA K"
                            },
                            {
                                "name": "SOKAWA Y"
                            },
                            {
                                "name": "IWAKURA Y"
                            }
                        ]
                    },
                    "publication_date": "2001",
                    "publication_name": {
                        "ja": "Gene"
                    },
                    "volume": "271",
                    "number": "2",
                    "starting_page": "261",
                    "ending_page": "271",
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/S0378-1119(01)00508-X"
                        ],
                        "issn": [
                            "0378-1119"
                        ],
                        "cinii_na_id": [
                            "80012770561"
                        ],
                        "pm_id": [
                            "11418248"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/S0378-1119(01)00508-X",
                            "is_downloadable": false
                        },
                        {
                            "label": "cinii_articles",
                            "@id": "http://ci.nii.ac.jp/naid/80012770561",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/11418248",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0013595/misc/10579145",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0013595/misc",
                    "rm:id": "10579145",
                    "rm:user_id": "1000029445",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000029445",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-09-24T15:00:00Z",
                    "rm:modifier_id": "B000000004",
                    "rm:modifier_type": "system",
                    "rm:modified": "2009-09-24T15:00:00Z",
                    "paper_title": {
                        "en": "Cloning of a novel 2',5'-oligoadenylate synthetase-like molecule, Oasl5 in mice"
                    },
                    "publication_date": "2001",
                    "publication_name": {
                        "en": "Gene"
                    },
                    "volume": "271",
                    "number": "2",
                    "starting_page": "261",
                    "ending_page": "271",
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/S0378-1119(01)00508-X"
                        ],
                        "issn": [
                            "0378-1119"
                        ],
                        "cinii_na_id": [
                            "80012770561"
                        ],
                        "pm_id": [
                            "11418248"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/S0378-1119(01)00508-X",
                            "is_downloadable": false
                        },
                        {
                            "label": "cinii_articles",
                            "@id": "http://ci.nii.ac.jp/naid/80012770561",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/11418248",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0013595/misc/10579173",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0013595/misc",
                    "rm:id": "10579173",
                    "rm:user_id": "1000029445",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000029445",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-09-24T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-04-17T04:47:03Z",
                    "paper_title": {
                        "en": "2 ',5 '-oligoadenylate synthetase gene in chicken: gene structure, distribution of alleles and their expression"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "R Tatsumi"
                            },
                            {
                                "name": "K Hamada"
                            },
                            {
                                "name": "S Sekiya"
                            },
                            {
                                "name": "M Wakamatsu"
                            },
                            {
                                "name": "T Namikawa"
                            },
                            {
                                "name": "M Mizutani"
                            },
                            {
                                "name": "Y Sokawa"
                            }
                        ]
                    },
                    "description": {
                        "en": "We have cloned the gene for chicken 2',5'-oligoadenylate synthetase (ChOAS) by the method of polymerase chain reaction with use of ChOAS cDNA sequence. The ChOAS gene is composed of five introns and six exons containing all of the sequence of the ChOAS cDNA from the start to the stop codon. The first five exons of ChOAS gene which encode the OAS catalytic domain have a similar structure to HuOAS1 gene including the exon-intron boundaries. However, the length of introns of ChOAS gene is only 1/7 of those of HuOAS1 gene. The sixth exon of the ChOAS gene encodes the ubiquitin-like (UbL) domain of two consecutive sequence (UbL1 and UbL2) homologous to ubiquitin. ChOAS encoded in a single copy gene has at least two alleles, OAS*A and OAS*B. The differences between these two alleles are in the sixth exon of the gene; a 96-nucleotide sequence in the UbL1 portion of OAS*A is deleted from OAS*B. No OAS*B gene was detected in nine lines of chickens tested other than Leghorns. Almost the same levels of ChOAS-A and -B proteins induced physiologically in erythrocytes were detected in infant chickens (2-week-old), but in grown-up chickens (6-month-old) the level of erythrocyte OAS-B was markedly reduced in most of BIB chickens. Thus, the UbL domain of ChOAS is responsible for the maintenance of the OAS level in the tissue. (C) 2000 Elsevier Science B.V. All rights reserved."
                    },
                    "publisher": {
                        "en": "ELSEVIER SCIENCE BV"
                    },
                    "publication_date": "2000-12",
                    "publication_name": {
                        "en": "BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION"
                    },
                    "volume": "1494",
                    "number": "3",
                    "starting_page": "263",
                    "ending_page": "268",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/S0167-4781(00)00174-3"
                        ],
                        "issn": [
                            "0167-4781"
                        ],
                        "wos_id": [
                            "WOS:000165570300008"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/S0167-4781(00)00174-3",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000165570300008&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0013595/misc/10579143",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0013595/misc",
                    "rm:id": "10579143",
                    "rm:user_id": "1000029445",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000029445",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-09-24T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-04-17T04:47:03Z",
                    "paper_title": {
                        "en": "2 ',5 '-oligoadenylate synthetase gene in chicken: gene structure, distribution of alleles and their expression"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "R Tatsumi"
                            },
                            {
                                "name": "K Hamada"
                            },
                            {
                                "name": "S Sekiya"
                            },
                            {
                                "name": "M Wakamatsu"
                            },
                            {
                                "name": "T Namikawa"
                            },
                            {
                                "name": "M Mizutani"
                            },
                            {
                                "name": "Y Sokawa"
                            }
                        ]
                    },
                    "description": {
                        "en": "We have cloned the gene for chicken 2',5'-oligoadenylate synthetase (ChOAS) by the method of polymerase chain reaction with use of ChOAS cDNA sequence. The ChOAS gene is composed of five introns and six exons containing all of the sequence of the ChOAS cDNA from the start to the stop codon. The first five exons of ChOAS gene which encode the OAS catalytic domain have a similar structure to HuOAS1 gene including the exon-intron boundaries. However, the length of introns of ChOAS gene is only 1/7 of those of HuOAS1 gene. The sixth exon of the ChOAS gene encodes the ubiquitin-like (UbL) domain of two consecutive sequence (UbL1 and UbL2) homologous to ubiquitin. ChOAS encoded in a single copy gene has at least two alleles, OAS*A and OAS*B. The differences between these two alleles are in the sixth exon of the gene; a 96-nucleotide sequence in the UbL1 portion of OAS*A is deleted from OAS*B. No OAS*B gene was detected in nine lines of chickens tested other than Leghorns. Almost the same levels of ChOAS-A and -B proteins induced physiologically in erythrocytes were detected in infant chickens (2-week-old), but in grown-up chickens (6-month-old) the level of erythrocyte OAS-B was markedly reduced in most of BIB chickens. Thus, the UbL domain of ChOAS is responsible for the maintenance of the OAS level in the tissue. (C) 2000 Elsevier Science B.V. All rights reserved."
                    },
                    "publisher": {
                        "en": "ELSEVIER SCIENCE BV"
                    },
                    "publication_date": "2000-12",
                    "publication_name": {
                        "en": "BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION"
                    },
                    "volume": "1494",
                    "number": "3",
                    "starting_page": "263",
                    "ending_page": "268",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/S0167-4781(00)00174-3"
                        ],
                        "issn": [
                            "0167-4781"
                        ],
                        "wos_id": [
                            "WOS:000165570300008"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/S0167-4781(00)00174-3",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000165570300008&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0013595/misc/10579172",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0013595/misc",
                    "rm:id": "10579172",
                    "rm:user_id": "1000029445",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000029445",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-09-24T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-07T04:43:23Z",
                    "paper_title": {
                        "en": "The clinical significance of core promoter and precore mutations during the natural course and interferon therapy in patients with chronic hepatitis B"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "M Shindo"
                            },
                            {
                                "name": "K Hamada"
                            },
                            {
                                "name": "S Koya"
                            },
                            {
                                "name": "Y Sokawa"
                            },
                            {
                                "name": "T Okuno"
                            }
                        ]
                    },
                    "description": {
                        "en": "OBJECTIVE: We aimed to determine the clinical significance of mutations in core promoter and precore regions in chronic hepatitis B. We investigated changes in these mutations during the natural course and interferon therapy in patients with chronic hepatitis B.\nMETHODS: A total of 93 patients with hepatitis B virus surface antigen were divided into four groups according to hepatitis B e antigen (HBeAg)/anti-HBe status and serum aminotransferase levels. Group I (n = 16) comprised HBeAg-positive patients with normal aminotransferase levels, group n (n = 31) HBeAg-positive patients with elevated aminotransferase levels, group III (n = 30) anti-HBe-positive patients with normal aminotransferase levels, and group IV (n = 16) anti-HBe-positive patients with elevated aminotransferase levels. All patients of group II and seven of group IV were treated with interferon. Three serial serum samples per untreated patient and eight samples per treated patient were tested for HBV DNA levels and core promoter and precore mutations by polymerase chain reaction combined with restriction fragment length polymorphism, and some were cloned and sequenced.\nRESULTS: Core promoter mutation was found in 38% of group I, 74% of group II, 97% of group III, and 100% of group IV. Precore mutation was found in 6% of group I, 90% of group II, and 100% of groups III and IV. The HBV DNA levels were significantly higher in groups I, II, IV, and III, in that order. Serial determination of these two mutations and viral levels showed that the core promoter mutation appeared to occur first, followed by a completion of the precore mutation along with a decrease in viral levels in patients who seroconverted to anti-HBe after interferon therapy. Interferon therapy suppressed both precore wild- and mutated-type viral levels equally. However, it did not induce any specific mutations.\nCONCLUSIONS: Core promoter mutation appeared to develop or complete first, followed by completion of the precore mutation, and the virus with these two mutations seemed to be the form to persist in the natural course of chronic hepatitis B. The clinical significance of these mutations appeared to be profoundly associated with the viral levels. (Am J Gastroenterol 1999;94:2237-2245. (C) 1999 by Am. Cell. of Gastroenterology)."
                    },
                    "publisher": {
                        "en": "ELSEVIER SCIENCE INC"
                    },
                    "publication_date": "1999-08",
                    "publication_name": {
                        "en": "AMERICAN JOURNAL OF GASTROENTEROLOGY"
                    },
                    "volume": "94",
                    "number": "8",
                    "starting_page": "2237",
                    "ending_page": "2245",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1111/j.1572-0241.1999.01299.x"
                        ],
                        "issn": [
                            "0002-9270"
                        ],
                        "wos_id": [
                            "WOS:000081868900039"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1111/j.1572-0241.1999.01299.x",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000081868900039&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0013595/misc/10579142",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0013595/misc",
                    "rm:id": "10579142",
                    "rm:user_id": "1000029445",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000029445",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-09-24T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-07T04:43:23Z",
                    "paper_title": {
                        "en": "The clinical significance of core promoter and precore mutations during the natural course and interferon therapy in patients with chronic hepatitis B"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "M Shindo"
                            },
                            {
                                "name": "K Hamada"
                            },
                            {
                                "name": "S Koya"
                            },
                            {
                                "name": "Y Sokawa"
                            },
                            {
                                "name": "T Okuno"
                            }
                        ]
                    },
                    "description": {
                        "en": "OBJECTIVE: We aimed to determine the clinical significance of mutations in core promoter and precore regions in chronic hepatitis B. We investigated changes in these mutations during the natural course and interferon therapy in patients with chronic hepatitis B.\nMETHODS: A total of 93 patients with hepatitis B virus surface antigen were divided into four groups according to hepatitis B e antigen (HBeAg)/anti-HBe status and serum aminotransferase levels. Group I (n = 16) comprised HBeAg-positive patients with normal aminotransferase levels, group n (n = 31) HBeAg-positive patients with elevated aminotransferase levels, group III (n = 30) anti-HBe-positive patients with normal aminotransferase levels, and group IV (n = 16) anti-HBe-positive patients with elevated aminotransferase levels. All patients of group II and seven of group IV were treated with interferon. Three serial serum samples per untreated patient and eight samples per treated patient were tested for HBV DNA levels and core promoter and precore mutations by polymerase chain reaction combined with restriction fragment length polymorphism, and some were cloned and sequenced.\nRESULTS: Core promoter mutation was found in 38% of group I, 74% of group II, 97% of group III, and 100% of group IV. Precore mutation was found in 6% of group I, 90% of group II, and 100% of groups III and IV. The HBV DNA levels were significantly higher in groups I, II, IV, and III, in that order. Serial determination of these two mutations and viral levels showed that the core promoter mutation appeared to occur first, followed by a completion of the precore mutation along with a decrease in viral levels in patients who seroconverted to anti-HBe after interferon therapy. Interferon therapy suppressed both precore wild- and mutated-type viral levels equally. However, it did not induce any specific mutations.\nCONCLUSIONS: Core promoter mutation appeared to develop or complete first, followed by completion of the precore mutation, and the virus with these two mutations seemed to be the form to persist in the natural course of chronic hepatitis B. The clinical significance of these mutations appeared to be profoundly associated with the viral levels. (Am J Gastroenterol 1999;94:2237-2245. (C) 1999 by Am. Cell. of Gastroenterology)."
                    },
                    "publisher": {
                        "en": "ELSEVIER SCIENCE INC"
                    },
                    "publication_date": "1999-08",
                    "publication_name": {
                        "en": "AMERICAN JOURNAL OF GASTROENTEROLOGY"
                    },
                    "volume": "94",
                    "number": "8",
                    "starting_page": "2237",
                    "ending_page": "2245",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1111/j.1572-0241.1999.01299.x"
                        ],
                        "issn": [
                            "0002-9270"
                        ],
                        "wos_id": [
                            "WOS:000081868900039"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1111/j.1572-0241.1999.01299.x",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000081868900039&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0013595/misc/10579141",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0013595/misc",
                    "rm:id": "10579141",
                    "rm:user_id": "1000029445",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000029445",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-09-24T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-06T12:00:06Z",
                    "paper_title": {
                        "en": "Characterization of a novel rat brain glycosylphosphatidylinositol-anchored protein (Kilon), a member of the IgLON cell adhesion molecule family"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "N Funatsu"
                            },
                            {
                                "name": "S Miyata"
                            },
                            {
                                "name": "H Kumanogoh"
                            },
                            {
                                "name": "M Shigeta"
                            },
                            {
                                "name": "K Hamada"
                            },
                            {
                                "name": "Y Endo"
                            },
                            {
                                "name": "Y Sokawa"
                            },
                            {
                                "name": "S Maekawa"
                            }
                        ]
                    },
                    "description": {
                        "en": "In the central nervous system, many cell adhesion molecules are known to participate in the establishment and remodeling of the neural circuit. Some of the cell adhesion molecules are known to be anchored to the membrane by the glycosylphosphatidylinositol (GPI) inserted to their C termini, and many GPI-anchored proteins are known to be localized in a Triton-insoluble membrane fraction of low density or so-called \"raft,\" In this study, we surveyed the GPI-anchored proteins in the Triton-insoluble low density fraction from 2-week-old rat brain by solubilization with phosphatidylinositol-specific phospholipase C, By Western blotting and partial peptide sequencing after the deglycosylation with peptide N-glycosidase F, the presence of Thy-1, F3/contactin, and T-cadherin was shown. In addition, one of the major proteins, having an apparent molecular mass of 36 kDa after the peptide N-glycosidase F digestion, was found to be a novel protein, The result of cDNA cloning showed that the protein is an immunoglobulin superfamily member with three C2 domains and has six putative glycosylation sites. Since this protein shows high sequence similarity to IgLON family members including LAMP, OBCAM, neurotrimin, CEPU-1, AvGP50, and GP55, we termed this protein Kilon (a kindred of IgLON). Kilon-specific monoclonal antibodies were produced, and Western blotting analysis showed that expression of Kilon is restricted to brain, and Kilon has an apparent molecular mass of 46 kDa in SDS-polyacrylamide gel electrophoresis in its expressed form, In brain, the expression of Kilon is already detected in E16 stage, and its level gradually increases during development. Kilon immunostaining was observed in the cerebral cortex and hippocampus, in which the strongly stained puncta were observed on dendrites and soma of pyramidal neurons."
                    },
                    "publisher": {
                        "en": "AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC"
                    },
                    "publication_date": "1999-03",
                    "publication_name": {
                        "en": "JOURNAL OF BIOLOGICAL CHEMISTRY"
                    },
                    "volume": "274",
                    "number": "12",
                    "starting_page": "8224",
                    "ending_page": "8230",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "cinii_na_id": [
                            "80010960446"
                        ],
                        "doi": [
                            "10.1074/jbc.274.12.8224"
                        ],
                        "issn": [
                            "0021-9258"
                        ],
                        "pm_id": [
                            "10075727"
                        ],
                        "wos_id": [
                            "WOS:000079268100086"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "cinii_articles",
                            "@id": "http://ci.nii.ac.jp/naid/80010960446",
                            "is_downloadable": false
                        },
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1074/jbc.274.12.8224",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/10075727",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000079268100086&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0013595/misc/10579171",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0013595/misc",
                    "rm:id": "10579171",
                    "rm:user_id": "1000029445",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000029445",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-09-24T15:00:00Z",
                    "rm:modifier_id": "B000000004",
                    "rm:modifier_type": "system",
                    "rm:modified": "2009-09-24T15:00:00Z",
                    "paper_title": {
                        "ja": "Characterization of a novel rat brain glycosyl- phosphatidylinositol- anchored protein (Kilon), a member of the IgLON cell adhesion molecule family"
                    },
                    "authors": {
                        "ja": [
                            {
                                "name": "FUNATSU N"
                            },
                            {
                                "name": "MIYATA S"
                            },
                            {
                                "name": "KUMANOGOH H"
                            },
                            {
                                "name": "SHIGETA M"
                            },
                            {
                                "name": "HAMADA K"
                            },
                            {
                                "name": "ENDO Y"
                            },
                            {
                                "name": "SOKAWA Y"
                            },
                            {
                                "name": "MAEKAWA S"
                            }
                        ]
                    },
                    "publication_date": "1999",
                    "publication_name": {
                        "ja": "J. Biol. Chem."
                    },
                    "volume": "274",
                    "number": "12",
                    "starting_page": "8224",
                    "ending_page": "8230",
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1074/jbc.274.12.8224"
                        ],
                        "issn": [
                            "0021-9258"
                        ],
                        "cinii_na_id": [
                            "80010960446"
                        ],
                        "pm_id": [
                            "10075727"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1074/jbc.274.12.8224",
                            "is_downloadable": false
                        },
                        {
                            "label": "cinii_articles",
                            "@id": "http://ci.nii.ac.jp/naid/80010960446",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/10075727",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0013595/misc/10579170",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0013595/misc",
                    "rm:id": "10579170",
                    "rm:user_id": "1000029445",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000029445",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-09-24T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-04-25T13:44:00Z",
                    "paper_title": {
                        "en": "Production of immunoreactive 2 ',5 '-oligoadenylate synthetase in p48-deficient mice"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "T Ueda"
                            },
                            {
                                "name": "R Tatsumi"
                            },
                            {
                                "name": "N Tanaka"
                            },
                            {
                                "name": "M Asada-Kubota"
                            },
                            {
                                "name": "K Hamada"
                            },
                            {
                                "name": "S Maekawa"
                            },
                            {
                                "name": "S Noguchi"
                            },
                            {
                                "name": "T Taniguchi"
                            },
                            {
                                "name": "Y Sokawa"
                            }
                        ]
                    },
                    "description": {
                        "en": "2',5'-Oligoadenylate synthetase (2'5'OAS), an enzyme induced by interferon (IFN), is physiologically produced in IFN-untreated normal healthy mice, The enzyme is localized mainly in the epithelium of the digestive tract, reproductive organs, and the choroid plexus in the brain, 2'5'OAS is also detected in oocytes in the ovary and in neurons and glial cells of both the telencephalon and cerebellum, Here, we examined the role of p48 (ISGF3 gamma), a component of IFN-stimulated gene factor 3 (ISGF3), in the physiologic production of 2'5'OAS using p48-deficient mice generated by gene targeting, In the p48-deficient mice, the physiologic production of 2'5'OAS localized in the following cells was severely impaired: hepatocytes, Kupffer cells, splenocytes, epithelium of the large intestine, oviduct, and uterus, and neurons and glial cells in both the telencephalon and cerebellum, The results show that 2'5'OAS in these cells is induced physiologically through a pathway including p48, However, the production of 2'5'OAS in oocytes was not affected in the p48-deficient mice, indicating that oocyte 2'5'OAS is produced through a p48-independent pathway, A possible function of the GAS sequence found in the promoter region of the 2'5'OAS gene to which Stat6 may bind also is discussed."
                    },
                    "publisher": {
                        "en": "MARY ANN LIEBERT INC PUBL"
                    },
                    "publication_date": "1998-03",
                    "publication_name": {
                        "en": "JOURNAL OF INTERFERON AND CYTOKINE RESEARCH"
                    },
                    "volume": "18",
                    "number": "3",
                    "starting_page": "181",
                    "ending_page": "185",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "issn": [
                            "1079-9907"
                        ],
                        "wos_id": [
                            "WOS:000072894100006"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000072894100006&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0013595/misc/10579140",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0013595/misc",
                    "rm:id": "10579140",
                    "rm:user_id": "1000029445",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000029445",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-09-24T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-04-25T13:44:00Z",
                    "paper_title": {
                        "en": "Production of immunoreactive 2 ',5 '-oligoadenylate synthetase in p48-deficient mice"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "T Ueda"
                            },
                            {
                                "name": "R Tatsumi"
                            },
                            {
                                "name": "N Tanaka"
                            },
                            {
                                "name": "M Asada-Kubota"
                            },
                            {
                                "name": "K Hamada"
                            },
                            {
                                "name": "S Maekawa"
                            },
                            {
                                "name": "S Noguchi"
                            },
                            {
                                "name": "T Taniguchi"
                            },
                            {
                                "name": "Y Sokawa"
                            }
                        ]
                    },
                    "description": {
                        "en": "2',5'-Oligoadenylate synthetase (2'5'OAS), an enzyme induced by interferon (IFN), is physiologically produced in IFN-untreated normal healthy mice, The enzyme is localized mainly in the epithelium of the digestive tract, reproductive organs, and the choroid plexus in the brain, 2'5'OAS is also detected in oocytes in the ovary and in neurons and glial cells of both the telencephalon and cerebellum, Here, we examined the role of p48 (ISGF3 gamma), a component of IFN-stimulated gene factor 3 (ISGF3), in the physiologic production of 2'5'OAS using p48-deficient mice generated by gene targeting, In the p48-deficient mice, the physiologic production of 2'5'OAS localized in the following cells was severely impaired: hepatocytes, Kupffer cells, splenocytes, epithelium of the large intestine, oviduct, and uterus, and neurons and glial cells in both the telencephalon and cerebellum, The results show that 2'5'OAS in these cells is induced physiologically through a pathway including p48, However, the production of 2'5'OAS in oocytes was not affected in the p48-deficient mice, indicating that oocyte 2'5'OAS is produced through a p48-independent pathway, A possible function of the GAS sequence found in the promoter region of the 2'5'OAS gene to which Stat6 may bind also is discussed."
                    },
                    "publisher": {
                        "en": "MARY ANN LIEBERT INC PUBL"
                    },
                    "publication_date": "1998-03",
                    "publication_name": {
                        "en": "JOURNAL OF INTERFERON AND CYTOKINE RESEARCH"
                    },
                    "volume": "18",
                    "number": "3",
                    "starting_page": "181",
                    "ending_page": "185",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "issn": [
                            "1079-9907"
                        ],
                        "wos_id": [
                            "WOS:000072894100006"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000072894100006&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/read0013595/books_etc",
            "@type": "books_etc",
            "@reverse": "https://api.researchmap.jp/read0013595",
            "total_items": 4,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0013595/books_etc/1330265",
                    "@type": "books_etc",
                    "@reverse": "https://api.researchmap.jp/read0013595/books_etc",
                    "rm:id": "1330265",
                    "rm:user_id": "1000029445",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000029445",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-09-24T15:00:00Z",
                    "rm:modifier_id": "1000029445",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2009-09-24T15:00:00Z",
                    "book_title": {
                        "ja": "生物工学実験書(共著)"
                    },
                    "publisher": {
                        "ja": "培風館"
                    },
                    "publication_date": "1992",
                    "referee": false
                },
                {
                    "@id": "https://api.researchmap.jp/read0013595/books_etc/1330264",
                    "@type": "books_etc",
                    "@reverse": "https://api.researchmap.jp/read0013595/books_etc",
                    "rm:id": "1330264",
                    "rm:user_id": "1000029445",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000029445",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-09-24T15:00:00Z",
                    "rm:modifier_id": "1000029445",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2009-09-24T15:00:00Z",
                    "book_title": {
                        "en": "Biotechnology Handbook"
                    },
                    "publisher": {
                        "en": "BAIFUKAN(Tokyo, Japan)"
                    },
                    "publication_date": "1992",
                    "referee": false
                },
                {
                    "@id": "https://api.researchmap.jp/read0013595/books_etc/1330266",
                    "@type": "books_etc",
                    "@reverse": "https://api.researchmap.jp/read0013595/books_etc",
                    "rm:id": "1330266",
                    "rm:user_id": "1000029445",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000029445",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-09-24T15:00:00Z",
                    "rm:modifier_id": "1000029445",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2009-09-24T15:00:00Z",
                    "book_title": {
                        "ja": "Cloned trans-acting factors that bind to the regulatory elements of the major histocompatibility complex class I gene. in \"Transgenic mice and mutants in MHC research\", eds. I. K. Egorov and C.S. David."
                    },
                    "publisher": {
                        "ja": "Springer-Verlag Berlin Heidelberg"
                    },
                    "publication_date": "1990",
                    "referee": false
                },
                {
                    "@id": "https://api.researchmap.jp/read0013595/books_etc/1330263",
                    "@type": "books_etc",
                    "@reverse": "https://api.researchmap.jp/read0013595/books_etc",
                    "rm:id": "1330263",
                    "rm:user_id": "1000029445",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000029445",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-09-24T15:00:00Z",
                    "rm:modifier_id": "1000029445",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2009-09-24T15:00:00Z",
                    "book_title": {
                        "en": "Cloned trans-acting factors that bind to the regulatory elements of the major histocompatibility complex class I gene"
                    },
                    "publisher": {
                        "en": "Springer-Verlag Berlin Heiderberg \"Transgenic Mice and Mutants in MHC Research.\""
                    },
                    "publication_date": "1990",
                    "referee": false
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/read0013595/association_memberships",
            "@type": "association_memberships",
            "@reverse": "https://api.researchmap.jp/read0013595",
            "total_items": 6,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0013595/association_memberships/1114848",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/read0013595/association_memberships",
                    "rm:id": "1114848",
                    "rm:user_id": "1000029445",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000029445",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-09-24T15:00:00Z",
                    "rm:modifier_id": "1000029445",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2009-09-24T15:00:00Z",
                    "academic_society_name": {
                        "ja": "米国遺伝学会(Genetics Society of America)"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0013595/association_memberships/1114847",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/read0013595/association_memberships",
                    "rm:id": "1114847",
                    "rm:user_id": "1000029445",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000029445",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-09-24T15:00:00Z",
                    "rm:modifier_id": "1000029445",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2009-09-24T15:00:00Z",
                    "academic_society_name": {
                        "ja": "米国微生物学会(American Society for Microbiology)"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0013595/association_memberships/1114846",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/read0013595/association_memberships",
                    "rm:id": "1114846",
                    "rm:user_id": "1000029445",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000029445",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-09-24T15:00:00Z",
                    "rm:modifier_id": "1000029445",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2009-09-24T15:00:00Z",
                    "academic_society_name": {
                        "ja": "日本分子生物学会"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0013595/association_memberships/1114845",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/read0013595/association_memberships",
                    "rm:id": "1114845",
                    "rm:user_id": "1000029445",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000029445",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-09-24T15:00:00Z",
                    "rm:modifier_id": "1000029445",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2009-09-24T15:00:00Z",
                    "academic_society_name": {
                        "en": "Genetics Society of America"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0013595/association_memberships/1114844",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/read0013595/association_memberships",
                    "rm:id": "1114844",
                    "rm:user_id": "1000029445",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000029445",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-09-24T15:00:00Z",
                    "rm:modifier_id": "1000029445",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2009-09-24T15:00:00Z",
                    "academic_society_name": {
                        "en": "American Society for Microbiology"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0013595/association_memberships/1114843",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/read0013595/association_memberships",
                    "rm:id": "1114843",
                    "rm:user_id": "1000029445",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000029445",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-09-24T15:00:00Z",
                    "rm:modifier_id": "1000029445",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2009-09-24T15:00:00Z",
                    "academic_society_name": {
                        "en": "The Molecular Biology Society of Japan"
                    }
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/read0013595/research_projects",
            "@type": "research_projects",
            "@reverse": "https://api.researchmap.jp/read0013595",
            "total_items": 2,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0013595/research_projects/1580138",
                    "@type": "research_projects",
                    "@reverse": "https://api.researchmap.jp/read0013595/research_projects",
                    "rm:id": "1580138",
                    "rm:user_id": "1000029445",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000029445",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-09-24T15:00:00Z",
                    "rm:modifier_id": "1000029445",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2009-09-24T15:00:00Z",
                    "research_project_title": {
                        "ja": "Interferon inducible protein 2-5A synthetase"
                    },
                    "overall_grant_amount": {
                        "indirect_cost": "0",
                        "total_cost": "0",
                        "direct_cost": "0"
                    },
                    "fund_type": "competitive_research_funding"
                },
                {
                    "@id": "https://api.researchmap.jp/read0013595/research_projects/1580137",
                    "@type": "research_projects",
                    "@reverse": "https://api.researchmap.jp/read0013595/research_projects",
                    "rm:id": "1580137",
                    "rm:user_id": "1000029445",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000029445",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-09-24T15:00:00Z",
                    "rm:modifier_id": "1000029445",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2009-09-24T15:00:00Z",
                    "research_project_title": {
                        "en": "Interferon inducible protein 2-5A synthetase"
                    },
                    "overall_grant_amount": {
                        "indirect_cost": "0",
                        "total_cost": "0",
                        "direct_cost": "0"
                    },
                    "fund_type": "competitive_research_funding"
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/read0013595/industrial_property_rights",
            "@type": "industrial_property_rights",
            "@reverse": "https://api.researchmap.jp/read0013595",
            "total_items": 1,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0013595/industrial_property_rights/133141",
                    "@type": "industrial_property_rights",
                    "@reverse": "https://api.researchmap.jp/read0013595/industrial_property_rights",
                    "rm:id": "133141",
                    "rm:user_id": "1000029445",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000029445",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-09-24T15:00:00Z",
                    "rm:modifier_id": "1000029445",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2009-09-24T15:00:00Z",
                    "industrial_property_right_type": "patent_right",
                    "industrial_property_right_title": {
                        "ja": "薬剤耐性構造タンパク質遺伝子を選択遺伝子として用いた発現ベクター"
                    },
                    "description": {
                        "ja": "特開平６−３８７７３"
                    }
                }
            ]
        }
    ]
}